Type 2 diabetes screening in at-risk patients may not decrease mortality risk

By mdCurrent-India staff | Published: Nov 2012 Volume: 1.

Population-based screening for type 2 diabetes in at-risk patients did not decrease the risk of diabetes-related mortality within 10 years, a recently published study found. Additionally, neither cardiovascular nor all-cause mortality risk was reduced.

Key Point: Population-based diabetes screening did not decrease diabetes-related or all-cause mortality within 10 years in a recent study of at-risk patients. Patients with detectable disease indicated through clinical signs and symptoms should still receive early diagnosis and treatment, and high-risk patients should be counseled about prevention.

Type 2 diabetes is on the rise globally, including in India. This public health challenge has given rise to questions about whether...